How Benzinga’s view on $SLS changed

Channel profile →This channel has 14 credited speakers: Broadcom CEO Hock Tan, Counterpoint Research, Goldman Sachs, JP Morgan, Jeff Kilberg (KKM Financial), Jim Cramer / George Kurtz, Ken Langone, Lion, Rothschild (rejected), Swing Baron, Third party cited in the quote, Tim Melvin / Lawrence Chang, Timothy Horan (Oppenheimer), Tom Saznoff1 entry
2026-10-19
“Earnings Week: $META, $TSLA, $NFLX Take Center Stage | PreMarket Playbook | October 19, 2026”
SLS's pre-clinical data announcement looks only mildly interesting; volume is up but the stock has come down recently, and overall there is nothing really exciting in SLS right now.

Nothing really. Most activives spies Q's Micron SLS Nebus Tesla Core Weave SpaceX APLD moving to most active

SLS SLS announces pre-clinical data. That looks a little interesting. Let's just take a look at a recent chart of SLS 9 minutes till the market open and then this thing gets easy then the news starts writing itself 52 week high in SLS is$139 to 1588 Volume is up.

It's actually come down recently from 12. So, nothing really exciting there.